Drug recall D-1309-2019
Product
Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.
Reason for recall
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Lots and codes
Lot #: 8H57901589, Exp. 09/2020; 9H57900189 and 9H57900289, Exp. 12/2020.
Recall details
- Recalling firm
- Novartis Pharmaceuticals Corp., East Hanover, NJ
- Quantity
- 792 cartons
- Distribution
- Nationwide with in the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 11, 2019
- Terminated
- November 28, 2023
Related products
- Promacta – drug information
- NDC 0078-0685 Promacta · Eltrombopag Olamine 25 mg/1 · Novartis Pharmaceuticals Corporation
- NDC 0078-0684 Promacta · Eltrombopag Olamine 12.5 mg/1 · Novartis Pharmaceuticals Corporation
- NDC 0078-0687 Promacta · Eltrombopag Olamine 75 mg/1 · Novartis Pharmaceuticals Corporation
- NDC 0078-0972 Promacta · Eltrombopag Olamine 12.5 mg/1 · Novartis Pharmaceuticals Corporation
- NDC 0078-0697 Promacta · Eltrombopag Olamine 25 mg/1 · Novartis Pharmaceuticals Corporation
- NDC 0078-0686 Promacta · Eltrombopag Olamine 50 mg/1 · Novartis Pharmaceuticals Corporation